Literature DB >> 8890808

A model that predicts morbidity and mortality after coronary artery bypass graft surgery.

J A Magovern1, T Sakert, G J Magovern, D H Benckart, J A Burkholder, G A Liebler, G J Magovern.   

Abstract

OBJECTIVES: This study was performed to develop a method for identifying patients at increased risk for morbidity or mortality after coronary artery bypass graft surgery.
BACKGROUND: Postoperative morbidity is more common than mortality and is important because of its relation to cost.
METHODS: Univariate and forward stepwise logistic regression analysis was used to retrospectively analyze a group of 1,567 consecutive patients who underwent bypass surgery between July 1991 and December 1992. We developed a model that predicted postoperative morbidity or mortality, or both, which was then prospectively validated in a group of 1,235 consecutive patients operated on between January 1993 and April 1994. A clinical risk score was derived from the model to simplify utilization of the data.
RESULTS: The following factors, listed in decreasing order of significance, were found to be significant independent predictors: cardiogenic shock, emergency operation, catheterization-induced coronary artery closure, severe left ventricular dysfunction, increasing age, cardiomegaly, peripheral vascular disease, chronic renal insufficiency, diabetes mellitus, low body mass index, female gender, reoperation, anemia, cerebrovascular disease, chronic obstructive pulmonary disease, renal dysfunction, low albumin, elevated blood urea nitrogen, congestive heart failure and atrial arrhythmias. Observed morbidity and mortality for the validation group fell within the 95% confidence interval of that predicted by the model. Costs were closely related to the incidence of postoperative morbidity.
CONCLUSIONS: Analysis of preoperative patient variables can predict patients at increased risk for morbidity or mortality, or both, after bypass surgery. Increased morbidity results in higher costs. Different strategies for high and low risk patients should be used in cost reduction efforts.

Entities:  

Mesh:

Year:  1996        PMID: 8890808     DOI: 10.1016/S0735-1097(96)00310-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  18 in total

Review 1.  Guideline for the management of patients with acute coronary syndromes without persistent ECG ST segment elevation. British Cardiac Society Guidelines and Medical Practice Committee and Royal College of Physicians Clinical Effectiveness and Evaluation Unit.

Authors: 
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

2.  Stratification of adverse outcomes by preoperative risk factors in coronary artery bypass graft patients: an artificial neural network prediction model.

Authors:  Chee-Fah Chong; Yu-Chuan Li; Tzong-Luen Wang; Hang Chang
Journal:  AMIA Annu Symp Proc       Date:  2003

3.  Transfusion practices among patients who did and did not predonate autologous blood before elective cardiac surgery.

Authors:  J Y Dupuis; B Bart; G Bryson; J Robblee
Journal:  CMAJ       Date:  1999-04-06       Impact factor: 8.262

4.  Presurgical serum cystatin C and risk of acute kidney injury after cardiac surgery.

Authors:  Michael G Shlipak; Steven G Coca; Zhu Wang; Prasad Devarajan; Jay L Koyner; Uptal D Patel; Heather Thiessen-Philbrook; Amit X Garg; Chirag R Parikh
Journal:  Am J Kidney Dis       Date:  2011-05-20       Impact factor: 8.860

Review 5.  Serum creatinine role in predicting outcome after cardiac surgery beyond acute kidney injury.

Authors:  Mahdi Najafi
Journal:  World J Cardiol       Date:  2014-09-26

6.  Preoperative statin is associated with decreased operative mortality in high risk coronary artery bypass patients.

Authors:  James A Magovern; Robert J Moraca; Stephen H Bailey; David A Dean; Kathleen A Simpson; Thomas D Maher; Daniel H Benckart; George J Magovern
Journal:  J Cardiothorac Surg       Date:  2010-02-24       Impact factor: 1.637

7.  Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials.

Authors:  Jean-Louis Vincent; Marc-Jacques Dubois; Roberta J Navickis; Mahlon M Wilkes
Journal:  Ann Surg       Date:  2003-03       Impact factor: 12.969

Review 8.  Risk assessment methods for cardiac surgery and intervention.

Authors:  Nassir M Thalji; Rakesh M Suri; Kevin L Greason; Hartzell V Schaff
Journal:  Nat Rev Cardiol       Date:  2014-09-23       Impact factor: 32.419

9.  Coronary stenting versus coronary bypass surgery in patients with multiple vessel disease and significant proximal LAD stenosis: results from the ERACI II study.

Authors:  A Rodriguez; M Rodríguez Alemparte; J Baldi; J Navia; A Delacasa; D Vogel; R Oliveri; C Fernández Pereira; V Bernardi; W O'Neill; I F Palacios
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

10.  Preoperative Anemia is Associated with Increased Intraoperative Mortality in Patients Undergoing Cardiac Surgery.

Authors:  Arwa Z Al-Riyami; Balan Baskaran; Sathiya M Panchatcharam; Hilal Al-Sabti
Journal:  Oman Med J       Date:  2021-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.